Cargando…
Made in Europe: will artemisinin resistance emerge in French Guiana?
Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649934/ https://www.ncbi.nlm.nih.gov/pubmed/23641802 http://dx.doi.org/10.1186/1475-2875-12-152 |
_version_ | 1782269040650092544 |
---|---|
author | Nacher, Mathieu Guérin, Philippe J Demar-Pierre, Magalie Djossou, Félix Nosten, François Carme, Bernard |
author_facet | Nacher, Mathieu Guérin, Philippe J Demar-Pierre, Magalie Djossou, Félix Nosten, François Carme, Bernard |
author_sort | Nacher, Mathieu |
collection | PubMed |
description | Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster. |
format | Online Article Text |
id | pubmed-3649934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36499342013-05-10 Made in Europe: will artemisinin resistance emerge in French Guiana? Nacher, Mathieu Guérin, Philippe J Demar-Pierre, Magalie Djossou, Félix Nosten, François Carme, Bernard Malar J Opinion Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster. BioMed Central 2013-05-04 /pmc/articles/PMC3649934/ /pubmed/23641802 http://dx.doi.org/10.1186/1475-2875-12-152 Text en Copyright © 2013 Nacher et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Opinion Nacher, Mathieu Guérin, Philippe J Demar-Pierre, Magalie Djossou, Félix Nosten, François Carme, Bernard Made in Europe: will artemisinin resistance emerge in French Guiana? |
title | Made in Europe: will artemisinin resistance emerge in French Guiana? |
title_full | Made in Europe: will artemisinin resistance emerge in French Guiana? |
title_fullStr | Made in Europe: will artemisinin resistance emerge in French Guiana? |
title_full_unstemmed | Made in Europe: will artemisinin resistance emerge in French Guiana? |
title_short | Made in Europe: will artemisinin resistance emerge in French Guiana? |
title_sort | made in europe: will artemisinin resistance emerge in french guiana? |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649934/ https://www.ncbi.nlm.nih.gov/pubmed/23641802 http://dx.doi.org/10.1186/1475-2875-12-152 |
work_keys_str_mv | AT nachermathieu madeineuropewillartemisininresistanceemergeinfrenchguiana AT guerinphilippej madeineuropewillartemisininresistanceemergeinfrenchguiana AT demarpierremagalie madeineuropewillartemisininresistanceemergeinfrenchguiana AT djossoufelix madeineuropewillartemisininresistanceemergeinfrenchguiana AT nostenfrancois madeineuropewillartemisininresistanceemergeinfrenchguiana AT carmebernard madeineuropewillartemisininresistanceemergeinfrenchguiana |